COMMUNIQUÉS West-GlobeNewswire

HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle
11/03/2025
Charitable non-profits nationwide receive grants to advance healthcare, financial literacy, mental health, and basic human needs; Applicants encouraged to apply for next round of funding DRAPER, Utah, March 11, 2025 ( [...]
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
11/03/2025
BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next- [...]
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
11/03/2025
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation NEW YORK, March 11, 2025 (GLOBE [...]
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
11/03/2025
Company to Host Conference Call, March 19, 2025 at 4:30 p.m. ET SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome- [...]
Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line
11/03/2025
Investment Reinforces Woodstock’s Commitment to Growth and Operating Efficiency WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and [...]
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
11/03/2025
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading [...]
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
11/03/2025
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq [...]
AMPS Launches ClaimInsight: A Next-Generation Payment Integrity Suite Built for Accuracy, Speed, and Value
11/03/2025
PHOENIX, March 11, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (AMPS), a leader in healthcare cost containment and payment integrity solutions, today announced the launch of ClaimInsight , a cutting-edge [...]
Little Leaves Behavioral Services Expands in Maryland and Virginia
11/03/2025
Four new ABA therapy centers will open this summer to meet growing need for high-quality, early intervention resources for young children with autism SILVER SPRING, Md., March 11, 2025 (GLOBE NEWSWIRE) -- Little Leaves [...]
AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
11/03/2025
On-demand video webcast now available Includes latest updates on pancreatic cancer and bird flu clinical trials OCALA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]
GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
11/03/2025
LA JOLLA, CA, March 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
11/03/2025
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities. WEXFORD, Pa., [...]
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
11/03/2025
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience ( www.kaerusbio.com ), a clinical-stage biopharmaceutical company created by Medicxi for the development of therapeutics for rare genetic syndromes of [...]
Druid City Vital Care Recognized at Vital Care Infusion Services Annual Conference
10/03/2025
TUSCALOOSA, Ala., March 10, 2025 (GLOBE NEWSWIRE) -- Druid City Vital Care (“Druid City”) was recently recognized at the Vital Care Infusion Services annual conference in Orlando, FL. Three locations -- Tuscaloosa, AL, [...]
LifeMD Reports Fourth Quarter 2024 Results
10/03/2025
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 million Full-year cash [...]
Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
10/03/2025
All resolutions approved by bondholders Closing of Royalty Financing and receipt of first €130 million instalment expected shortly Upon closing of the Royalty Financing, GENFIT will implement the Repurchase of the 2025 [...]
Royalty Financing avec HCRx : GENFIT annonce l’approbation de la modification des modalités de ses OCEANEs 2025
10/03/2025
Approbation de toutes les résolutions par les porteurs d’OCEANEs 2025 Closing du Royalty Financing et réception de la première tranche de 130 millions d’euros attendus prochainement À la suite du closing du Royalty [...]
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
10/03/2025
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025
10/03/2025
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025 Mont-Saint-Guibert, Belgique – 10 mars 2025, 22h05 CET / 17h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« [...]

Pages